February 12, 2020

Deal Drivers EMEA FY2019

In partnership with Mergermarket

The new Deal Drivers report reveals that 2019 M&A activity in EMEA slowed from the peaks experienced in past years. The drop is unsurprising, given geopolitical and economic headwinds across the region: trade disputes, Brexit uncertainty and slowing economies all affected M&A activity in 2019. However, activity did not fall apace with the severe drop experienced in 2H18. Notably:

  • The pharma, medical & biotech sector in Europe had another extraordinary year, with a 15% rise on 2018;
  • Europe’s industrials & chemicals sector outperformed the other sectors by winning 20% of all deal volume across Europe;
  • Bucking global trends, European consumer sector M&A was up 26% from 2018.
  • Total M&A deal value in MENA (ex Israel) was €107.2bn, equal to the cumulative total of the prior four years;
  • The Saudi Aramco-SABIC deal was the largest in the global chemical space, at €62.5bn.

Read the full report to learn more about M&A activity and trends in the region, including heat charts, adviser league tables and sector analysis.

You may also like:

Datasite Forecaster November Global Outlook

Check out this month's Forecaster, where we provide a quick update on where the M&A market is heading, based on aggregated and anonymized data room activity.

907954412
Deal Drivers: APAC Q3 2022

Current macroeconomics presents a challenging environment for dealmakers to navigate. The data from Q3 2022 puts M&A in APAC at a critical juncture as dealmaking reaches pre-Covid levels. Will the markets normalize from here on or will they go into a downward spiral? Learn more from our latest Deal Drivers report.

Deal Drivers: Americas Q3 2022

A look back on M&A deal activity in the US, Canada and Latin America in Q3 2022. What regions and sectors look ripe for opportunity going forward? Find out in our latest report.

New York City Landscape